PIK3CA and breast carcinoma: Because TP53 is a multifunctional protein, some studies report improved outcomes with mutations while others report the opposite.[12] Similarly, studies report varying outcomes with mutations in PIK3CA.[13-15] The implications of various mutations become even more complex when specific subsets of breast cancer are evaluated.